Events Calendar Upcoming Events
METADiAB - The Sydney Practical Diabetes Forum at Royal Prince Alfred (RPA) Hospital Diabetes Centre - LIVE BROADCAST
When |
Saturday 29 October 2022 | 8:30am - 4:30pm AEDT |
Where |
VIRTUAL PLATFORM: Two days prior to the meeting, confirmation details |
The METADiAB Forum is RACGP accredited and designed to provide GPs with a comprehensive update on diabetes management. It aims to improve patient outcomes by supporting GPs to individualise diabetes management when escalating therapy beyond metformin. Attendees of the Forum will gain practical insights into the latest thinking and guidance in the management of diabetes and metabolic health. The emphasis will be on real-world issues and changes that can be implemented in your clinical practice the following week. The Forum will be interactive, case-based, and with ample time for discussion and questions. It is free to attend for General Practitioners and it has been accredited by the RACGP for 12 CPD points.
We welcome and look forward to your participation at this informative and important chronic disease educational initiative.
Objectives:
The METADiAB Forum is an RACGP accredited CPD activity designed to provide GPs with a comprehensive update on diabetes management. It aims to improve patient outcomes by supporting GPs to individualise diabetes management amongst patients with comorbidities such as obesity, cardiovascular disease and renal complications.
After completing this activity participants of the Forum can expect to:
- Identify the major complications of type 2 diabetes and recent changes in evidence in the treatment of heart failure and renal complications in the context of diabetes
- Describe the use of different glucose monitors in the management of diabetes
- Develop a comprehensive management plan utilising the latest guidelines individualised to patient needs, including risk factors and weight management
- Evaluate the different levels of evidence that underlie the recent change in thinking regarding the treating cardiovascular and renal risk in type 2 diabetes
Back